Nifty Pharma Today: Close, Stocks, Breadth and Performance

Updated: 19 Oct 2026 • 4:07 pm

Posted by:

Nifty Pharma Today: Close, Stocks, Breadth and Performance

Nifty Pharma today closed in the red, reflecting a weak session across most pharmaceutical stocks in the index. The index ended at 25,615, down 166.65 points or 0.65%, as declines in a large majority of constituents outweighed gains in only a few names. For investors tracking sector performance, this was a session defined by broad-based selling pressure rather than a fall caused by just one or two stocks.

The day’s pattern also matters. Nifty Pharma opened at 25,769.3, moved up to an intraday high of 26,020.45, and then slipped to a low of 25,565.4 before settling near the lower end of the day’s range. That intraday reversal suggests that early strength did not sustain and sellers retained control into the close.

Table of Contents

Nifty Pharma Index Snapshot

Metric	Value
Current Value	25,615
Absolute Change	-166.65
Percentage Change	-0.65%
Opening Value	25,769.3
Previous Close	25,781.65
Day High	26,020.45
Day Low	25,565.4
Market Status	Closed
Last Updated	19 October 2026 at 4:00:00 PM IST
Market Trend	Bearish

Nifty Pharma finished below both its opening level and previous close, which confirms that the session weakened as the day progressed. The index briefly traded above the prior close early in the day, but the inability to hold that strength was a key signal. Because the close came very close to the day’s low, the final print indicates continued selling pressure into the end of the session.

In plain language, pharma stocks as a group had a negative day. While a handful of stocks still managed gains, they were not enough to offset declines across the rest of the basket. When an index falls and closes near the lower end of its intraday range, it usually means sellers had the upper hand for most of the latter part of the trading session.

Quick Summary

Nifty Pharma closed at 25,615, down 0.65%, after giving up early gains and sliding toward the day’s low by the close. The move was driven less by one isolated event and more by widespread weakness across constituents, with 16 declining stocks against only 3 advancing stocks. Natco Pharma, Dr. Reddy's Laboratories, and Laurus Labs were the main positive movers, while JB Chemicals & Pharmaceuticals, Aurobindo Pharma, and Biocon were among the biggest drags. Investors should now watch whether breadth improves in the next session and whether recent underperformers continue to pressure the index.

Why Nifty Pharma Moved Today

The clearest explanation for today’s Nifty Pharma decline is the breadth of the fall. Out of 20 constituents, 16 closed lower and only 3 ended in the green, while 1 stock was unchanged. That kind of distribution usually points to broad selling across the sector rather than stock-specific pressure in only a narrow pocket of the index.

The intraday path supports the same reading. Nifty Pharma opened only slightly below the previous close, rose to 26,020.45, and then reversed lower. A session that starts relatively stable, tests higher levels, and then closes near the low often suggests that buying interest was not strong enough to absorb later supply. In market terms, early optimism faded and sellers dominated into the close.

The constituent list also shows that the declines were spread across multiple pharma names. Stocks such as JB Chemicals & Pharmaceuticals, Aurobindo Pharma, Biocon, Granules India, Lupin, Abbott India, Ipca Laboratories, Mankind Pharma, Alkem Laboratories, and Sun Pharmaceutical Industries all closed lower. When weakness is this widely distributed, the sector index typically struggles to recover even if a few stocks post gains.

On the positive side, Natco Pharma rose 2.01%, Dr. Reddy's Laboratories gained 0.77%, and Laurus Labs added 0.43%. Those advances show that there was some selective buying within the sector. However, the positive moves were too limited in number to change the overall tone of the day.

So the most reliable explanation for today’s move is simple: Nifty Pharma fell because the majority of its constituents declined, and the index lost momentum after failing to hold its early high. That combination of weak breadth and an intraday reversal created a bearish close.

Market Breadth

Breadth Metric	Value
Advancing Stocks	3
Declining Stocks	16
Unchanged Stocks	1
Advance-Decline Ratio	0.19
Stocks in Green	15%
Stocks in Red	80%

Market breadth was decisively negative. Only 15% of the index constituents finished in the green, while 80% closed in the red. The advance-decline ratio of 0.19 means that for roughly every one advancing stock, there were more than five declining stocks.

This matters because breadth often tells a deeper story than the headline index move. An index can sometimes fall because a few large components drag it lower, even when many smaller constituents rise. That was not the case here. Today’s breadth indicates widespread weakness, which usually points to a more convincing bearish session at the sector level.

For short-term observers, this breadth profile suggests caution. A weak breadth reading means the selling pressure was not isolated. For medium-term watchers, the next important question is whether this poor breadth was a one-day event or the start of a broader stretch of underperformance within the pharma pack.

Complete Constituent Performance

Company	CMP	Today's %	Today's Change	Volume	Trend
JB Chemicals & Pharmaceuticals Ltd.	2,408.9	-3.87%	-97.1	4,779,224	Bearish
Aurobindo Pharma Ltd.	1,621.4	-2.73%	-45.5	736,433	Bearish
Biocon Ltd.	340	-2.63%	-9.2	3,222,416	Bearish
Granules India Ltd.	806.05	-2.34%	-19.3	874,275	Bearish
Natco Pharma Ltd.	800.85	2.01%	15.8	768,065	Bullish
Lupin Ltd.	1,939.2	-1.14%	-22.4	602,008	Bearish
Abbott India Ltd.	25,905	-1.01%	-265	2,009	Bearish
Ipca Laboratories Ltd.	1,814.5	-0.99%	-18.1	167,626	Bearish
Mankind Pharma Ltd.	2,253.2	-0.98%	-22.3	1,228,705	Bearish
Alkem Laboratories Ltd.	5,004	-0.91%	-46	95,218	Bearish
Sun Pharmaceutical Industries Ltd.	1,743	-0.9%	-15.8	829,445	Bearish
Ajanta Pharma Ltd.	3,298.9	-0.9%	-30.1	36,644	Bearish
Zydus Lifesciences Ltd.	1,113.9	-0.81%	-9.1	253,448	Bearish
Gland Pharma Ltd.	3,019.8	-0.78%	-23.6	167,122	Bearish
Dr. Reddy's Laboratories Ltd.	1,242.5	0.77%	9.5	1,023,837	Bullish
Glenmark Pharmaceuticals Ltd.	2,210.2	-0.74%	-16.5	285,702	Bearish
Divi's Laboratories Ltd.	9,087	-0.63%	-57.5	448,972	Bearish
Laurus Labs Ltd.	2,069	0.43%	8.9	1,133,053	Bullish
Cipla Ltd.	1,324.1	-0.08%	-1	1,387,215	Bearish
Torrent Pharmaceuticals Ltd.	4,558.7	0%	-0.2	250,305	Sideways

The best performer in the index was Natco Pharma, which rose 2.01%. The worst performer was JB Chemicals & Pharmaceuticals, which fell 3.87%. Those two stocks framed the outer edge of today’s sector move.

The broader table shows how widespread the weakness was. Several stocks declined by close to or more than 1%, and only three names managed gains. When losses are distributed across diversified pharma businesses rather than concentrated in one corner of the sector, the index tends to reflect a more durable negative tone for that session.

Top Stocks Supporting the Index

Company	Price Change	% Move	Reason Behind Move
Natco Pharma Ltd.	15.8	2.01%	Among the few constituents to attract buying interest and finish firmly in the green.
Dr. Reddy's Laboratories Ltd.	9.5	0.77%	Held gains through the session and helped offset part of the broader sector weakness.
Laurus Labs Ltd.	8.9	0.43%	Closed higher in a weak market, showing relative resilience versus most peers.

These three gainers were important because they prevented the sector from falling more sharply. Natco Pharma led the advances by a comfortable margin, while Dr. Reddy's Laboratories and Laurus Labs added modest support. Still, with only three gainers in the entire index, their contribution was defensive rather than trend-changing.

Another useful observation is that the positive side was narrow. A healthy uptrend usually needs broad participation. Today’s gainers list was short, which means the buying was selective and not strong enough to lift the overall pharma basket.

Top Draggers on Nifty Pharma

Company	Price Change	% Move	Reason Behind Fall
JB Chemicals & Pharmaceuticals Ltd.	-97.1	-3.87%	Sharp selling pressure made it the weakest stock in the index for the day.
Aurobindo Pharma Ltd.	-45.5	-2.73%	One of the largest percentage declines in the basket, adding to sector weakness.
Biocon Ltd.	-9.2	-2.63%	Extended the negative breadth by closing among the steepest decliners.
Granules India Ltd.	-19.3	-2.34%	Meaningful decline that reinforced the downbeat tone across pharma shares.
Lupin Ltd.	-22.4	-1.14%	Closed lower and added to the cumulative drag from multiple mid-to-large constituents.

JB Chemicals & Pharmaceuticals stood out clearly as the biggest drag of the day after falling 3.87%. Aurobindo Pharma and Biocon also posted significant losses, while Granules India and Lupin added to the downside pressure. These declines did not occur in isolation; they came alongside losses in many other constituents, which amplified the index impact.

This is an important distinction for investors. A sector index can often shrug off one weak stock, but it becomes far harder to do so when several prominent names decline together. That was the pattern today, and it explains why the Nifty Pharma close stayed weak.

How Nifty Pharma Performed Versus Other Market Indices

Index	Close	Change	Change %	Relative View vs Nifty Pharma
Nifty IT	31,516.3	-407.8	-1.28%	Nifty Pharma outperformed
Nifty Metal	12,066.4	-66.8	-0.55%	Nifty Pharma underperformed
Nifty Bank	55,488.1	-355.9	-0.64%	Nearly in line; Nifty Pharma slightly underperformed
Nifty Financial Services	24,987.1	-400	-1.58%	Nifty Pharma outperformed
Nifty Auto	25,591.25	-177.25	-0.69%	Nifty Pharma outperformed slightly
Nifty FMCG	43,975.5	-640.65	-1.44%	Nifty Pharma outperformed
Nifty Pharma	25,615	-166.65	-0.65%	—
Nifty Mid Select	13,565.15	-152.25	-1.11%	Nifty Pharma outperformed

Nifty Pharma was weak, but not the weakest part of the market. It performed better than Nifty IT, Nifty Financial Services, Nifty FMCG, and Nifty Mid Select. It was roughly in line with Nifty Bank and slightly better than Nifty Auto. Only Nifty Metal held up better among the listed indices.

This comparison adds useful context. The pharma index had a negative day, but the broader market tone across several sectors was also soft. That means the decline in Nifty Pharma was part of a wider risk-off session across many pockets of the market, even though its own breadth remained especially poor.

Price Structure and Session Analysis

At the index level, the most notable technical feature of the day was the intraday reversal. Nifty Pharma moved above its previous close and touched 26,020.45, but then sold off and finished at 25,615. The close near the day’s low of 25,565.4 indicates that sellers remained in control into the final phase of the session.

That type of structure is generally considered short-term bearish because it shows rejection at higher levels. In simple terms, buyers pushed the index up early, but they were unable to sustain those levels. Sellers then regained control and drove the index back down.

The day’s range was 455.05 points, calculated from the high of 26,020.45 and low of 25,565.4. Closing close to the bottom of such a range usually reflects weak sentiment at the end of trade. If a market closes near its high, that often signals strength carrying into the next session. The reverse happened here.

Within the constituents, the same structure appeared in several names. A number of stocks opened near or at the previous close and still ended lower, which suggests fading intraday conviction. The combination of weak breadth, an index close near the session low, and only three advancing stocks points to a negative short-term tone for the sector.

Stock Activity and Participation

Trading activity helps show where attention was concentrated inside the index. Among the actively traded names, JB Chemicals & Pharmaceuticals recorded volume of 4,779,224 shares with turnover of 1,151.27 crore, making it one of the session’s standout counters in terms of participation. Its steep 3.87% fall also meant that high activity came alongside clear selling pressure.

Other actively traded stocks included Cipla with volume of 1,387,215 shares, Mankind Pharma with 1,228,705 shares, Laurus Labs with 1,133,053 shares, and Dr. Reddy's Laboratories with 1,023,837 shares. This mix is interesting because it included both gainers and losers, showing that investor activity was elevated across the sector rather than limited to one direction.

Divi's Laboratories also drew attention with turnover of 407.98 crore, despite a relatively moderate fall of 0.63%. High turnover paired with a contained decline can sometimes indicate active two-way trade rather than one-sided panic. In contrast, JB Chemicals & Pharmaceuticals combined very high turnover with the sharpest price fall, which marked it as the day’s most pressured stock.

Activity metrics do not tell investors why a stock moved, but they do show where market participation was concentrated. Today, the high-volume and high-turnover list reinforces the broader message of the session: Nifty Pharma weakness was supported by active trading, not by a thin or inactive market.

Short-Term and Longer-Period Stock Performance

Company	1 Month	3 Months	6 Months	1 Year	5 Years
Aurobindo Pharma Ltd.	-5.37%	3.96%	18.54%	47.48%	127.55%
Biocon Ltd.	-13.92%	-22.11%	-5.31%	-6.67%	-1.28%
Granules India Ltd.	-7.9%	-8%	21.31%	42.46%	152.09%
Natco Pharma Ltd.	-1.89%	-15.76%	-27.2%	-3.93%	-9.21%
Lupin Ltd.	-8.72%	-21.76%	-16.73%	-0.24%	106.65%
Abbott India Ltd.	-3.91%	-6.24%	3.77%	-11.42%	28.85%
Ipca Laboratories Ltd.	-9.65%	-1.31%	23.55%	42.76%	54.95%
Mankind Pharma Ltd.	-7.57%	-12.18%	5.09%	-8.22%	58.42%
Alkem Laboratories Ltd.	-6.71%	-11.49%	-11.31%	-9.95%	30.24%
Sun Pharmaceutical Industries Ltd.	-6.74%	-10.91%	4.46%	3.22%	110.67%
Ajanta Pharma Ltd.	-6.87%	-4.9%	18.61%	35.41%	128.88%
Zydus Lifesciences Ltd.	-4.06%	-3.05%	18.94%	11.13%	111.33%
Gland Pharma Ltd.	2.71%	22.8%	68.27%	56.89%	-19.2%
Dr. Reddy's Laboratories Ltd.	3.69%	1.59%	0.8%	-3.08%	29.38%
Glenmark Pharmaceuticals Ltd.	-9.79%	-1.31%	-0.92%	19.29%	328.62%
Divi's Laboratories Ltd.	-3.44%	24.17%	44.7%	37.6%	75.02%
Laurus Labs Ltd.	2.55%	32.72%	83.18%	124.73%	235.33%
Cipla Ltd.	-4.47%	-8.15%	7.69%	-19.22%	46.12%
Torrent Pharmaceuticals Ltd.	-8.28%	-8.92%	8.77%	27.68%	196.7%

Looking beyond one session, the constituent return profile shows a more mixed and nuanced sector picture. Laurus Labs stands out strongly with gains of 32.72% over three months, 83.18% over six months, and 124.73% over one year. Divi's Laboratories and Gland Pharma have also delivered strong medium-term performance, even though both were under pressure today.

On the weaker side, Biocon has struggled across multiple periods, including negative returns over three months, six months, and one year. Natco Pharma, despite being today’s top gainer, remains negative over three months, six months, and one year. This contrast highlights an important market lesson: one-day strength does not always reverse a weaker medium-term trend, and one-day weakness does not necessarily cancel out a strong longer trend.

For investors studying Nifty Pharma today, this longer-period return table shows that the sector is not moving in lockstep beneath the surface. Some constituents still have very strong trailing momentum, while others remain in corrective phases.

What Investors Should Watch Next

The next session should be watched through three simple lenses. First is breadth: if the number of advancing stocks improves meaningfully from today’s 3 against 16 decliners, it could indicate that today’s weakness was temporary. If breadth remains this poor, the bearish tone may continue.

Second is the intraday structure of the index. Today’s close near the low signaled weak end-of-day demand. Investors should watch whether Nifty Pharma can hold above its opening range in the next session or whether sellers again overwhelm early buying attempts.

Third is stock-level follow-through in the most influential movers of the day. Natco Pharma, Dr. Reddy's Laboratories, and Laurus Labs showed resilience. On the other side, JB Chemicals & Pharmaceuticals, Aurobindo Pharma, Biocon, and Granules India saw sharper selling. The next move in these stocks can help reveal whether the sector is stabilizing or whether pressure is spreading further.

Activity is also worth monitoring. Today’s high volumes in stocks such as JB Chemicals & Pharmaceuticals, Cipla, Mankind Pharma, Laurus Labs, and Dr. Reddy's Laboratories suggest that investors were actively repositioning within pharma. Continued heavy participation in subsequent sessions could provide clues about whether the market is building a base or extending weakness.

Key Takeaways

Nifty Pharma closed at 25,615, down 166.65 points or 0.65%.
The index opened at 25,769.3, hit 26,020.45, fell to 25,565.4, and closed near the day’s low.
Market breadth was weak: 3 advancers, 16 decliners, and 1 unchanged stock.
Natco Pharma was the top gainer at 2.01%, followed by Dr. Reddy's Laboratories and Laurus Labs.
JB Chemicals & Pharmaceuticals was the top loser at -3.87%, followed by Aurobindo Pharma and Biocon.
Nifty Pharma underperformed Nifty Metal, was nearly in line with Nifty Bank, and outperformed several other sector indices such as IT, FMCG, Financial Services, and Mid Select.
The session’s structure was bearish because the index failed to hold early strength and ended close to the intraday low.

Frequently Asked Questions

1. How did Nifty Pharma close today?

Nifty Pharma closed at 25,615 on 19 October 2026, down 166.65 points or 0.65% from the previous close of 25,781.65. The index also finished near its intraday low, which reflected weak momentum into the closing hour.

2. Why did Nifty Pharma fall today?

Nifty Pharma fell mainly because selling was broad-based across the index. Sixteen of the 20 constituents ended lower, while only three gained. The index also reversed after touching an intraday high, showing that early strength could not be sustained.

3. Which stock gained the most in Nifty Pharma today?

Natco Pharma was the top gainer in Nifty Pharma today. It rose 15.8 points, or 2.01%, to close at 800.85. It was one of only three stocks in the index to finish the session in positive territory.

4. Which stock fell the most in Nifty Pharma today?

JB Chemicals & Pharmaceuticals was the top loser in Nifty Pharma today. It declined 97.1 points, or 3.87%, to close at 2,408.9. It also saw very high trading activity during the session.

5. How was the market breadth of Nifty Pharma today?

Nifty Pharma breadth was weak. The index had 3 advancing stocks, 16 declining stocks, and 1 unchanged stock. That means only 15% of constituents closed in the green, while 80% ended in the red.

6. What does the advance-decline ratio of 0.19 mean for Nifty Pharma?

An advance-decline ratio of 0.19 indicates that decliners heavily outnumbered advancers. In practical terms, there was roughly one advancing stock for every five-plus declining stocks, which signals broad weakness across the sector rather than isolated pressure.

7. How did Nifty Pharma compare with other sector indices today?

Nifty Pharma fell 0.65%, so it outperformed weaker indices such as Nifty IT, Nifty Financial Services, Nifty FMCG, and Nifty Mid Select. It was close to Nifty Bank, slightly better than Nifty Auto, but weaker than Nifty Metal.

8. Which Nifty Pharma stocks were most actively traded today?

Among the actively traded Nifty Pharma stocks were JB Chemicals & Pharmaceuticals, Cipla, Mankind Pharma, Laurus Labs, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries. Their volumes and turnover show that participation remained strong despite the sector’s weak close.

9. What does Nifty Pharma track?

Nifty Pharma is a sector index that tracks listed pharmaceutical companies within the Indian equity market. It is used by investors to understand how the pharma space is performing as a group rather than judging the sector through one individual stock.

10. How many stocks are in Nifty Pharma, and what should investors watch next?

Nifty Pharma had 20 constituents in this review. Investors should watch whether breadth improves in the next session, whether the index can avoid another close near the day’s low, and whether today’s top gainers and losers show follow-through.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.